This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Infacare Pharmaceutical Corporation. Active years: 2008-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2012
Title: The Innovative Contributions of Danny Levin
Introduction
Danny Levin is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of chemistry, particularly in the preparation of metal mesoporphyrin compounds. With a total of 2 patents, Levin's work showcases his dedication to advancing scientific knowledge and practical applications.
Latest Patents
Levin's latest patents focus on the preparation of metal mesoporphyrin compounds. One of his patents describes a method for preparing metal mesoporphyrin halide compounds. This process involves forming a novel mesoporphyrin IX intermediate compound, which is then converted to the metal mesoporphyrin halide through metal insertion. The intermediate compound is created by a catalytic hydrogenation of hemin in acid, followed by its recovery. Another patent similarly outlines a method for preparing metal mesoporphyrin compounds, emphasizing the innovative approach of using the mesoporphyrin IX intermediate.
Career Highlights
Danny Levin is associated with Infacare Pharmaceutical Corporation, where he applies his expertise in chemistry to develop new pharmaceutical solutions. His work at Infacare highlights his commitment to improving healthcare through innovative research and development.
Collaborations
Levin collaborates with talented individuals such as Robert Vukovich and Benjamin Levinson. These partnerships enhance the creative process and contribute to the successful development of new inventions.
Conclusion
Danny Levin's contributions to the field of chemistry, particularly through his patents on metal mesoporphyrin compounds, demonstrate his innovative spirit and commitment to scientific advancement. His work continues to influence the pharmaceutical industry and inspire future inventors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile